ASKA Pharmaceutical HoldingsLtd Balance Sheet Health
Financial Health criteria checks 6/6
ASKA Pharmaceutical HoldingsLtd has a total shareholder equity of ¥60.4B and total debt of ¥10.1B, which brings its debt-to-equity ratio to 16.7%. Its total assets and total liabilities are ¥94.9B and ¥34.5B respectively. ASKA Pharmaceutical HoldingsLtd's EBIT is ¥5.6B making its interest coverage ratio -19.4. It has cash and short-term investments of ¥20.4B.
Key information
16.7%
Debt to equity ratio
JP¥10.11b
Debt
Interest coverage ratio | -19.4x |
Cash | JP¥20.35b |
Equity | JP¥60.39b |
Total liabilities | JP¥34.47b |
Total assets | JP¥94.86b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4886's short term assets (¥62.0B) exceed its short term liabilities (¥21.5B).
Long Term Liabilities: 4886's short term assets (¥62.0B) exceed its long term liabilities (¥12.9B).
Debt to Equity History and Analysis
Debt Level: 4886 has more cash than its total debt.
Reducing Debt: 4886's debt to equity ratio has reduced from 37.7% to 16.7% over the past 5 years.
Debt Coverage: 4886's debt is well covered by operating cash flow (47.3%).
Interest Coverage: 4886 earns more interest than it pays, so coverage of interest payments is not a concern.